Acquired Company
Larkspur Health Acquisition Corp. completed its business combination with ZyVersa Therapeutics, Inc. in December 2022, and the combined company began trading on Nasdaq on December 13, 2022 under the ticker ZVSA.
ZyVersa Therapeutics Inc. is a clinical-stage biopharmaceutical company located in Weston, Florida, focused on advancing innovative therapies for renal and inflammatory diseases. The company utilizes its proprietary technologies to develop a promising pipeline of drug candidates that target significant unmet medical needs, aiming to enhance patient outcomes and improve therapeutic strategies within its specialized fields. With a strong emphasis on research and development, ZyVersa is strategically positioned to contribute to transformative changes in the biopharmaceutical landscape. Show more
Location: 2200 N. COMMERCE PARKWAY, WESTON, FL, UNITED STATES, 33326, Weston, FL, 33326, USA | Website: https://www.zyversa.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
1.295M
52 Wk Range
$0.11 - $1.46
Previous Close
$0.17
Open
$0.16
Volume
8,677
Day Range
$0.16 - $0.17
Enterprise Value
-1.742M
Cash
528K
Avg Qtr Burn
-1.407B
Insider Ownership
0.03%
Institutional Own.
5.15%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Cholesterol Efflux Mediator™ VAR 200 Details Diabetic Kidney Disease | Phase 2a Data readout |